CD1D and obesity due to melanocortin 4 receptor deficiency: Given the capacity of CD1d to modulate lipid metabolism and inflammatory responses (Brailey et al., 2022), it is likely that its cell-intrinsic functions could play a role in the progression of metabolic diseases including obesity.